SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients

NCT04673383 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: SPL026
DRUG: Placebo

Sponsor

Small Pharma Ltd